Its prognostic value was particularly evident in patients with preserved global and longitudinal systolic function (LVEF ≥50% or GLS > 12%), supporting the notion that RASP provides additional risk stratification beyond conventional systolic indices in severe AS.6 The gene discussed is HHAT; the disease is aortic stenosis.